CONSIDERAŢII GENERALE ASUPRA SPECIILOR DE CANDIDA IMPLICATE ÎN ETIOLOGIA INFECȚIOR MICOTICE
PDF

Як цитувати

Burduniuc, O., Guțu, N., Bivol, M., & Balan Greta, B. G. (2021). CONSIDERAŢII GENERALE ASUPRA SPECIILOR DE CANDIDA IMPLICATE ÎN ETIOLOGIA INFECȚIOR MICOTICE. InterConf, (53). вилучено із https://ojs.ukrlogos.in.ua/index.php/interconf/article/view/12007
PDF

Посилання

Adhikary R., Joshi S. Species distribution and anti-fungal susceptibility of candidemia at a multi super-speciality center in Southern India. In: Ind J Med Microbiol. 2013;29: 309-11.

Bailly S., et al. Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years. In: J Infect. 2016;72(1):103-11.

Balan G., Burduniuc O., Ulinici M., Puscas N., Grumeza M., Guțu N. A study on biofilm production among Candida species. In: VIII Annual International Scientific-Practical Conference „Medicine pressing questions”. Baku, Аzerbaijan. 2019. p. 60. ISSN 978-9952-8279-6-4.

Balan G., Burduniuc, O. Antimicrobial susceptibility and biofilm production among Staphylococcus and Candida species. In: The Moldovan Medical Journal. Chișinău, 2020, 63 (1), 3-7. ISSN 2537-6373 (Print), ISSN 2537-6381.

Burduniuc O. Actualități în diagnosticul infecțiilor fungice invazive. În: Sănătate Publică, Economie şi Management în Medicină. 2019, nr. 2(80), pp. 54-60. ISSN 1729-8687.

Burduniuc O. Biofilmele fungice – provocare actuală la nivel mondial. În: Studia Universitatis Moldaviae, Seria “Științe Reale și ale Naturii”. Chișinău, 2020, 1(131), 100-110. ISSN 1814-3237, ISSN, Online 1857-498x.

Burduniuc O. Factorii de virulență a fungilor patogeni: semnificația clinică și detectarea fenotipică. În: Studia Universitatis, Seria Științe Reale și ale Naturii. 2018, 6(116), 3-13. ISSN 1814-3237.

Burduniuc O. Fungii patogeni și rezistența la antimicotice. Tipografia Print-Caro, 2018. 274 p., ISBN 978-9975-56-538-7.

Burduniuc O., Bîrcă E., Burduniuc A., Grumeza M., Bivol M. Distribuția speciilor clinice de candida și sensibilitatea acestora la antifungice. În: Sănătate Publică, Economie și Management în Medicină. 2020, 5(87), 31-36. ISSN 1729-8687

Burduniuc O., Mares M., Denning D.W. Burden of Serious Fungal Diseases in Republic of Moldova. In: Medical Mycology. 2018, 56, S1–S159 doi: 10.1093/mmy/myy036 p. S104 (IF: 2.799)

Cataldi V., Di Campli E., Fazii P., Traini T. Luigina Cellini1 and Mara Di Giulio1,∗Candida species isolated from different body sites and their antifungal susceptibility pattern: Crossanalysis of Candida albicans and Candida glabrata biofilms In: Medical Mycology, 2017, 55, 624–634.

Dharwad S., et al. Species identification of Candida isolates in various clinical specimens with their antifungal susceptibility patterns. In: J Clin Diagn Res. 2011 (suppl-1); 5(6): 1177-81.

Fleck R., Dietz A., Hof H. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. In: J Antimicrob Chemother. 2007;59:767–71.

Ghaddar N., Anastasiadis E., Halimeh R., Ghaddar A., Dhar R., AlFouzan W., Yusef H., El Chaar M. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon. In: BMC Infect Dis. 2020; 20(1):32. doi: 10.1186/s12879-019-4736-2. PMID: 31931738; PMCID: PMC6958632.

Ghazi S., et al. The epidemiology of Candida species in the Middle East and North Africa. In: J Mycol Med. 2019;29:245–52.

Golia S., Reddy K.M., Karjigi K.S., et al. Speciation of Candida using chromogenic and cornmeal agar with determination of fluconazole sensitivity. In: Al Ameen J Med Sci. 2013;6(2):163-6.

Jayalakshmi L., RatnaKumari G., Samson S.H. Isolation, speciation and antifungal susceptibility testing of candida from clinical specimens at a tertiary care hospital. In: Sch J App Med Sci. 2014;2:3193–8.

Kiraz N., Oz Y. Species distribution and in vitro antifungal susceptibility of clinical Candida isolates from a university hospital in Turkey over a 5-year period. In: Med Mycol. 2011;49:126–31.

Manikandan C., Amsath A. Characterization and susceptibility pattern of Candida species isolated from urine sample in pattukkottai, Tamilnadu, India. In: Int J Pure Appl Zool. 2015;3:17–23.

Mohandas V., Ballal M. Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in southern India. In: J Glob Infect Dis. 2011;3(1):4-8. doi:10.4103/0974-777X.77288.

Mondal A., et al. Species distribution and in vitro antifungal susceptibility patterns of Candida. In: J Inst Med. 2013;35:45–9.

Ogba O.M., et al. Characterization of Candida species isolated from cases of lower respiratory tract infection. In: World J AIDS 2013;3:201-6.

Pahwa N., Kumar R., Nirkhiwale S., et al. Species distribution and drug susceptibility of candida in clinical isolates from a Tertiary Care Centre at Indore. In: Indian J Med Microbiol. 2014;32(1):44-8.

Pușcaș N., Bălan G., Burduniuc O. Micro-test system for rapid isolation and identification of Candida species in urinary tract infections. In: Antropological Research and Studies. București, România. 2017, nr. 7, p. 64-70. ISSN 2360-3445; ISSN-L 2360 – 3445.

Rajeevan S., Thomas M., Appalaraju B. Characterisation and Antifungal susceptibility pattern of Candida species isolated from various clinical samples at a tertiary care centre in South India In: Indian J Microbiol Res 2016;3(1):53-57, DOI: 10.5958/2394-5478.2016.00014.5.

Sajjan A.C., Mahalakshmi V.V., Hajare V. Prevalence and antifungal susceptibility of Candida species isolated from patients attending tertiary care hospital. In: IOSR J Dent Med Sci. 2014;13:44–9.

Seyoum E., Bitew A. Mihret A. Distribution of Candida albicans and nonalbicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia. In: BMC Infect Dis. 2020; 20(1):231. doi: 10.1186/s12879-020-4883-5. PMID:32188422; PMCID: PMC7081544.

Sida H., Pethani J., Dalal P., et al. Study of Changing Trend in the Clinical Distribution of Candida Species in Various Clinical Samples at Tertiary Care Hospital, Ahmedabad, Gujarat. In: Ntl J Community Med. 2017;8:109–11.

Storti L. R., Pasquale1 G., Scomparim R., Galastri A. L., Walderez F. A., Rodrigues C. P. Candida spp. isolated from inpatients, the environment, and health practitioners in the Pediatric Unit at the Universitary Hospital of the Jundiaí Medical College. In: Revista da Sociedade Brasileira de Medicina Tropical State of São Paulo, Brazil 45(2):225-2312012.

Vijaya D., Harsha T.R., Nagaratanamma T. Candida speciation using CHROM agar. In: J Clin Diagn Res. 2011;5(4):755-7.

Yang C. W., Barkham T. M., Chan F.Y., Wang Y. Prevalence of Candida species, including Candida dubliniensis, in Singapore. In: J Clin Microbiol. 2003;41(1):472-474. doi:10.1128/jcm.41.1.472-474.2003.

Yesudhason B.L., Mohanram K. Candida tropicalis as a predominant isolate from clinical specimens and its antifungal susceptibility pattern in a Tertiary Care Hospital in Southern India. In: J Clin Diagn Res. 2015;9(7):DC14-6.

Creative Commons License

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.

Завантаження

Дані завантаження ще не доступні.

| Переглядів: 1 | Завантажень: 13 |